XML 23 R25.htm IDEA: XBRL DOCUMENT v3.3.0.814
Merger (Tables)
9 Months Ended
Sep. 30, 2015
Business Combinations [Abstract]  
Summary of Acquisition Date Fair Value of Consideration Transferred

The acquisition-date fair value of the consideration transferred is as follows:

 

Number of shares of Company Common Stock owned by Ruthigen stockholders (1)

     2,404,835   

Multiplied by the price per share of Company Common Stock (2)

   $ 12.65   
  

 

 

 

Total consideration transferred

   $ 30,421   
  

 

 

 

 

(1) The stock transferred in the table above is calculated as the sum of a) 1,921,716 shares of Company Common Stock outstanding at the time of the Merger, b) 379,387 shares of Company Common Stock issued immediately following the closing of the Merger in a private placement, c) 36,000 shares of Company Common Stock issued to certain employees, pursuant to the terms of the Merger Agreement and d) 67,732 shares of Company Common Stock issued pursuant to restricted stock units that became fully vested upon completion of the Merger.
(2) The shares outstanding are multiplied by the closing trading price of Company Common Stock as of the Merger date.
Summary of Estimated Fair Value of Assets Acquired and Liabilities Assumed

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition:

 

     June 15, 2015  

Cash and cash equivalents

   $ 9,671   

In-process research and development

     7,534   

Goodwill

     15,942   

Property and equipment

     156   

Prepaid and other current assets

     140   
  

 

 

 

Total assets acquired

     33,443   
  

 

 

 

Accrued expenses and other current liabilities

     (63

Deferred tax liability

     (2,959
  

 

 

 

Total liabilities assumed

     (3,022
  

 

 

 

Total net assets acquired

   $ 30,421   
  

 

 

 

 

 
Summary of Supplemental Unaudited Pro forma Information of Financial Results

The following supplemental unaudited pro forma information presents the Company’s financial results as if the acquisition of Ruthigen had occurred on January 1, 2014:

 

     Nine months ended September 30,  
     2015      2014  

Total revenues, net

   $ 926       $ 38   

Net loss

     (14,557      (29,195